PRIMECAP MANAGEMENT CO/CA/ - MARRONE BIO INNOVATIONS INC ownership

MARRONE BIO INNOVATIONS INC's ticker is MBII and the CUSIP is 57165B106. A total of 56 filers reported holding MARRONE BIO INNOVATIONS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
PRIMECAP MANAGEMENT CO/CA/ ownership history of MARRONE BIO INNOVATIONS INC
ValueSharesWeighting
Q2 2022$1,692,000
+3.1%
1,458,400
-4.0%
0.00%
+100.0%
Q1 2022$1,641,000
+43.8%
1,519,100
-4.1%
0.00%0.0%
Q4 2021$1,141,000
-25.5%
1,583,800
-6.8%
0.00%0.0%
Q3 2021$1,532,000
-52.0%
1,700,000
-11.6%
0.00%
-50.0%
Q2 2021$3,194,000
-21.1%
1,924,000
-0.7%
0.00%
-33.3%
Q1 2021$4,048,000
+63.3%
1,936,800
-2.3%
0.00%
+50.0%
Q4 2020$2,479,000
-0.2%
1,983,200
-2.6%
0.00%0.0%
Q3 2020$2,483,000
-3.1%
2,035,300
-7.1%
0.00%0.0%
Q2 2020$2,563,000
+39.4%
2,190,300
-2.7%
0.00%0.0%
Q1 2020$1,839,000
-21.5%
2,250,600
-3.0%
0.00%0.0%
Q4 2019$2,344,000
-29.3%
2,320,600
-1.3%
0.00%
-33.3%
Q3 2019$3,314,000
-10.9%
2,350,600
-5.2%
0.00%0.0%
Q2 2019$3,721,000
-7.2%
2,480,710
-5.3%
0.00%0.0%
Q1 2019$4,008,000
+3.8%
2,619,600
-0.2%
0.00%0.0%
Q4 2018$3,860,000
-19.7%
2,625,6000.0%0.00%0.0%
Q3 2018$4,805,000
-0.5%
2,625,6000.0%0.00%
-25.0%
Q2 2018$4,831,000
-8.0%
2,625,6000.0%0.00%0.0%
Q1 2018$5,251,000
+81.8%
2,625,6000.0%0.00%
+100.0%
Q4 2017$2,888,000
-5.4%
2,625,600
-1.1%
0.00%
-33.3%
Q3 2017$3,054,000
-12.4%
2,655,600
-1.7%
0.00%0.0%
Q2 2017$3,487,000
-34.3%
2,702,870
-0.6%
0.00%
-40.0%
Q1 2017$5,304,000
-12.8%
2,719,915
-4.3%
0.01%
-16.7%
Q4 2016$6,084,000
+21.1%
2,843,200
-2.7%
0.01%
+20.0%
Q3 2016$5,024,000
+100.3%
2,921,000
-4.5%
0.01%
+66.7%
Q2 2016$2,508,000
-13.3%
3,058,700
-4.9%
0.00%0.0%
Q1 2016$2,894,000
-18.8%
3,216,100
-0.7%
0.00%
-25.0%
Q4 2015$3,564,000
-47.9%
3,240,200
-0.1%
0.00%
-50.0%
Q3 2015$6,841,000
+6.6%
3,242,1000.0%0.01%
+33.3%
Q2 2015$6,419,000
-48.8%
3,242,1000.0%0.01%
-50.0%
Q1 2015$12,547,000
+7.2%
3,242,1000.0%0.01%0.0%
Q4 2014$11,704,000
+35.7%
3,242,1000.0%0.01%
+33.3%
Q3 2014$8,624,000
-75.6%
3,242,100
+6.6%
0.01%
-76.9%
Q2 2014$35,348,000
+68.5%
3,042,019
+102.5%
0.04%
+62.5%
Q1 2014$20,983,000
+195.7%
1,501,983
+276.3%
0.02%
+166.7%
Q4 2013$7,096,000
-3.2%
399,100
-8.3%
0.01%
-10.0%
Q3 2013$7,330,000435,0000.01%
Other shareholders
MARRONE BIO INNOVATIONS INC shareholders Q2 2020
NameSharesValueWeighting ↓
ARDSLEY ADVISORY PARTNERS LP 18,335,767$13,205,0002.52%
Shay Capital LLC 4,126,040$2,972,0000.49%
OAK FAMILY ADVISORS, LLC 418,690$302,0000.11%
FNY Investment Advisers, LLC 125,000$90,0000.05%
Artal Group S.A. 1,048,679$755,0000.02%
Long Focus Capital Management, LLC 100,000$72,0000.01%
Virtu Financial LLC 78,688$57,0000.01%
Southland Equity Partners LLC 22,000$15,8440.01%
Clear Harbor Asset Management, LLC 75,677$55,0000.01%
IndexIQ Advisors LLC 202,060$146,0000.01%
View complete list of MARRONE BIO INNOVATIONS INC shareholders